Australian life sciences incubator and accelerator programmes
The Australian biotechnology ecosystem is thriving, with the vast majority of companies developing therapeutics, diagnostics, devices, vaccines and other technologies in the very early stages of development.
Industry companies tend to be small and medium-sized enterprises, pre-revenue, pre-market access and on a journey of commercialisation. One of the common challenges is access to capital and opportunities to accelerate strategic planning in the very early stages of a company’s development.
Participating in incubator or accelerator programmes is an opportunity for early-stage companies to gain access to expertise, funding and introductions to potential investors: programmes designed to drive their innovations towards real-world outcomes
AusBiotech's summary of Australian life sciences incubator and accelerator programmes features programmes that are currently active, directly relevant to Australian life science companies and are available to registered Australian companies with established proof of concept. Each programme has specific eligibility and selection criteria and companies are encouraged to explore which option best suits their needs.
Programmes offering a specific focus on global market-entry strategy
These programmes aim to connect Australian life sciences companies to collaborators and investors in specific priority markets. The following programmes provide workshops and training domestically in Australia, along with access to funding and connectivity with investors and international networks.
